Lori Klein, PharmD

Lori leads the Medical and Scientific Affairs Practice at Putnam. Her expertise includes multi-stakeholder engagement, center of excellence profiling, organizational design, strategic medical launches, integrated medical evidence ideation, omnichannel strategy, and digital health platforms, including digital therapeutics, AI algorithms, and software as a medical device. Lori has experience in rare diseases including Duchenne muscular dystrophy, hemophilia, growth hormone deficiency, cardiac amyloidosis, acromegaly, sickle cell disease, and primary hyperoxaluria as well as oncology, infectious disease, cardiology, critical care, neurology, and endocrinology.

Prior to Putnam, Lori had a Medical Affairs strategy consultancy, built the Medical Affairs division at CDM and later became President. Earlier in her career she gained experience in medical education and MSL training at Bayer, and clinical research at the University of Minnesota.

Lori holds an RPh from the University of Iowa, a PharmD from the University of Minnesota, and completed a postdoctoral fellowship in critical care and infectious diseases at the University of Minnesota.